Introduction {#s1}
============

Organised inpatient care (stroke unit care), has been shown to improve outcome significantly after an acute stroke in randomised trials and observational studies in routine clinical practice.[@pone.0061581-Govan1]--[@pone.0061581-Langhorne1] Few studies, mostly trials, have examined longer term outcome (more than three months) with organised care after acute stroke and these have generally demonstrated long lasting benefits of stroke unit care up to 10 years after stroke.[@pone.0061581-Jorgensen1]--[@pone.0061581-Glader1] Observational studies examining longer term outcome (≥3months) after stroke unit care have used national data from hospital registers, or in one study, compared two community populations where one had a stroke unit and the other did not. [@pone.0061581-Jorgensen1], [@pone.0061581-Glader1] The survival advantage associated with stroke unit care has been shown to be relatively marked in specific subgroups of patients including younger patients, those with intracerebral haemorrhage and unconscious patients. [@pone.0061581-Terent1] Previous studies from South London have demonstrated inequalities in access to organised inpatient care across different socio-demographic and clinical groups, but the impact of these on longer term outcome in subgroups of patients remain unknown. [@pone.0061581-Addo1], [@pone.0061581-McKevitt1] Availability of such data is necessary for reviewing opportunities for optimising access to stroke services and delivering longer term support for stroke patients, in line with the Department of Health of England's, National Stroke Strategy. [@pone.0061581-Department1].

The aim of this study is to examine the associations between a range of evidence-based indicators of acute stroke care and death up to one year after a first-ever stroke in an unbiased population sample using data from the South London Stroke Register, and to determine the size of the effect across different socio-demographic and clinical subgroups of patients.

Materials and Methods {#s2}
=====================

Ethics {#s2a}
------

Patients or their relatives gave written informed consent to participate in the study. The design of the study was approved by the ethics committees of Guy\'s and St Thomas\' Hospital Trust, King\'s College Hospital, Queen's Square, and Westminster Hospital (London).

Identification of Stroke Patients {#s2b}
---------------------------------

Patients were recruited from the South London Stroke Register (SLSR), an ongoing population-based study of incidence and outcome, that has prospectively recorded first-ever stroke in a geographically defined area of South London since 1995. At the 2001 Census, the population of the SLSR area was 271 817, with 63% whites; 9% black Caribbean; 15% black African and 13% other ethnic groups. The detailed methods of notification of patients and data collection have been described previously. [@pone.0061581-Tilling1], [@pone.0061581-Stewart1] In brief, patients were identified by register nurses and doctors using multiple sources of notification and recruited to the register as soon as possible after stroke onset. Data from patients who had their stroke between January 1995 and December 2010 were included in this study. Patients with subarachnoid haemorrhage were excluded from the analyses (n = 212) because the majority are managed in neurosurgical units following different protocols.

Baseline Assessment {#s2c}
-------------------

Data on demographic details include age; sex; self-defined ethnicity (white, black and other ethnicity) and socioeconomic status (Registrar General's occupational codes grouped as manual and non-manual). Stroke severity measures obtained at the time of maximal impairment included urinary incontinence, Glasgow Coma Scale (GCS) classified as GCS \<9, 9--12 and GCS ≥13, swallowing deficits (assessed by use of the 3-oz water swallow test) [@pone.0061581-DePippo1], stroke subtype (ischemic stroke, primary intracerebral haemorrhage and undefined), and pre-stroke Barthel Index (BI) for activities of daily living categorised as: 0 to 9 (severe disability), 10--14 (moderate disability) 15 to 19 (mild disability) and 20 (functionally independent). [@pone.0061581-Wolfe1].

Patterns of Care and Acute Interventions {#s2d}
----------------------------------------

Data were available on a range of evidence-based process indicators suggested to be used to assess the quality of acute stroke care.[@pone.0061581-Kjellstrom1]--[@pone.0061581-Adams1] These included admission to a stroke unit and spending more than 50% of hospital admission on a stroke unit. A stroke unit was defined as a discrete area of a hospital ward that took care of stroke patients and had a specialist multidisciplinary team providing a complex package of care to stroke patients in hospital. [@pone.0061581-StrokeUnitTrialists1] Indicators of rehabilitation therapy provision (physiotherapy \[PT\] assessment within 72 hours; occupational therapy \[OT\] within seven days; and speech and language therapy \[SALT\]) within seven days for those with recorded deficits were examined for the period between 2005 and 2010 when the register collected data on these processes of care. The use of PT and OT was considered appropriate for patients who had any paralysis, visual field defects and sensory impairments in the acute phase. SALT was considered appropriate in patients with dysphasia, dysarthria, and dysphagia or failed swallow test. Another intervention for which data was collected between 2005 and 2010 only was the receipt of aspirin at anytime within the first week of stroke or within 48 hours if ischemic stroke.

Outcome Measure {#s2e}
---------------

The outcome measure evaluated was the time of death in the first year after stroke. Patients with no record of death were censored at the end of 2011. Information on death was obtained from medical records, general practitioners and next-of kin and confirmed by the Office of National Statistics.

Statistical Analysis {#s2f}
--------------------

In univariable analyses, one year cumulative survival rates in socio-demographic groups and by care received were calculated, with 95% confidence intervals using Kaplan-Meier methods. Survival functions were compared using Log-rank tests. Multivariable Cox models were used to test for interactions between components of care and age group, sex, ethnic group, socioeconomic status, stroke subtype and level of consciousness. Models were also fitted within each group to compare the relative survival associated with receipt of care across different groups. All models were adjusted for age, gender, ethnicity, socioeconomic status, stroke subtype, GCS, incontinence and motor deficits. The year of stroke was included in all models to allow for long term time trends in care received on stroke units. [@pone.0061581-Addo1] Receipt of aspirin within 48 hours was excluded from the multivariable analyses because of the low number of eligible patients not receiving it (n = 72 in total - and smaller in the subgroups). Patients with unknown and undefined stroke subtypes were excluded from multivariable analyses.

As interactions between patient group and care received were tested for 11 different interventions, a bonferroni adjustment was used and p\<0.05/11 = 0.005 considered statistically significant in multivariate analyses. All analyses were conducted using STATA 11MP.

Results {#s3}
=======

A total of 4026 patients with a first-ever stroke were registered between January 1995 and December 2010 with a mean age of 71.1 (SD 14.3) years. [Table 1](#pone-0061581-t001){ref-type="table"} shows the general characteristics and the cumulative survival by sub-groups of patients. Overall, 3535 (87.8%) of patients were admitted to hospital after their stroke and 1949 (56.4%) managed on a stroke unit. Between 2005 and 2010, 883 (84.1%) of patients with deficits received PT/OT and 550 (67.3%) received SALT. Patients who were managed on a stroke unit, those with deficits receiving specific rehabilitation therapies and those with ischaemic stroke who received aspirin in the acute phase had better one year survival compared to those who did not receive such acute care interventions.

10.1371/journal.pone.0061581.t001

###### General characteristics and cumulative survival at one year post stroke.

![](pone.0061581.t001){#pone-0061581-t001-1}

                                N (%)      Cumulative survival (95% CI)   p-value                                                 N (%)      Cumulativesurvival (95% CI)   p-value
  -------------------------- ------------ ------------------------------ ---------- ------------------------------------------ ------------ ----------------------------- ----------
  All                            4026                                                          **Care indicators**                                                        
  **Gender**                                                              \<0.0001          **Hospital** **admission**                                                     \<0.0001
  Male                        2033(50.5)         73.9(71.9--79.0)                                      Yes                      3535(87.8)        65.3(63.6--66.8)        
  Female                      1993(49.5)         62.3(60.1--64.4)                                       No                      491(12.2)         90.9(87.8--93.2)        
  **Age (years)**                                                         \<0.0001        **Stroke unit** **admission**                                                    \<0.0001
  \<65                        1172(29.1)         85.0(82.9--87.0)                                      Yes                      1949(56.4)        72.9(70.9--74.8)        
  65--74                      1050(26.1)         74.7(71.9--77.2)                                       No                      1510(43.7)        54.6(52.1--57.2)        
  75--84                      1175(29.2)         60.0(57.1--62.8)                      **50% of stay on** **a stroke unit**                                                \<0.0001
  85+                         629(15.6)          40.4(36.5--44.3)                                      Yes                      1451(46.5)        74.5(72.2--76.7)        
  **Ethnicity**                                                           \<0.0001                      No                      1667(53.5)        55.9(53.5--58.3)        
  White                       2894(73.7)         64.3(62.5--66.0)                               **Brain imaging**                                                          \<0.0001
  Black                       806(20.5)          80.1(77.1--82.7)                                      Yes                      3595(93.0)        70.3(68.8--71.8)        
  Other                        228(5.8)          81.3(75.5--85.8)                                       No                       269(7.0)         29.9(23.8--36.1)        
  **Socioeconomic status**                                                 0.0108             **Swallow test done**                                                         0.0680
  Non-manual                  1056(33.0)         80.6(78.0--82.9)                                      Yes                      3216(91.6)        65.6(63.9--67.2)        
  Manual                      2141(67.0)         72.6(70.7--74.5)                                       No                       295(8.4)         61.7(55.8--67.1)        
  **Subtype**                                                             \<0.0001   **Aspirin given in** **the acute phase**                                              \<0.0001
  Infarction                  3149(78.2)         71.4(69.8--77.5)                                      Yes                      840(85.0)         78.1(75.1--80.7)        
  PICH                        544(13.5)          57.3(52.8--61.5)                                       No                      148(15.0)         59.6(51.2--67.0)        
  Undefined                    187(4.6)          28.9(22.2--35.9)                      **Aspirin given** **within 48 hrs**                                                  0.1369
  Unknown                      146(3.6)          80.9(73.5--86.5)                                      Yes                      629(89.7)         77.4(73.9--80.5)        
  **GCS**                                                                 \<0.0001                      No                       72(10.3)         84.7(79.0--94.3)        
  \<9                         584(15.2)          18.7(15.4--22.2)                                    **PTOT**                                                              \<0.0001
  9--15                       470(12.2)          48.8(44.2--53.3)                                      Yes                      883(84.1)         73.8(70.7--76.6)        
  13--15                      2802(72.7)         80.3(78.8--81.8)                                       No                      167(15.9)         51.9(43.8--59.4)        
                                                                                                     **SALT**                                                              \<0.0001
                                                                                                       Yes                      550(67.3)         70.4(66.4--74.0)        
                                                                                                        No                      267(32.7)         56.8(50.5--62.6)        

Multivariate analyses testing for interactions between components of acute stroke care and socio-demographic as well as clinical sub-groups of patients are shown in [Tables 2](#pone-0061581-t002){ref-type="table"}--[5](#pone-0061581-t005){ref-type="table"}. There was a significant interaction between age and stroke unit care as shown in [Table 2](#pone-0061581-t002){ref-type="table"} (p = 0.0018). The relative effect was greatest in younger patients (\<65 year olds) where stroke unit admission was associated with a 61% decrease in hazard of death (HR 0.39; 95% CI: 0.25--0.62) compared to a 22% reduction in hazard (HR 0.78; 95% CI: 0.57--1.05) in older patients (85+ years). There was however no significant interaction between age and the other acute care interventions examined.

10.1371/journal.pone.0061581.t002

###### Relative hazard of death following receipt of acute care interventions by age group.

![](pone.0061581.t002){#pone-0061581-t002-2}

                                                                    Age, HR(95%CI)                                                            
  --------------------------------------------------------------- ------------------ ------------------ ------------------ ------------------ --------
  Hospital admission                                               2.38(0.74--7.68)   2.30(1.06--4.98)   2.531.32--4.84)    4.06(1.65--9.97)   0.9980
  Stroke unit admission                                            0.39(0.25--0.62)   0.64(0.46--0.91)   0.66(0.51--0.86)   0.78(0.57--1.05)   0.0018
  50% of stay on a stroke unit                                     0.44(0.25--0.75)   0.89 0.61--1.28)   0.71(0.83--0.95)   0.74(0.53--1.05)   0.0038
  50% of stay on a stroke unit[\*](#nt101){ref-type="table-fn"}    1.07(0.42--2.76)   1.22(0.69--2.17)   1.15(0.73--1.82)   0.85(0.51--1.42)   0.5279
  Brian imaging                                                    0.18(0.05--0.57)   0.62(0.22--1.77)   0.33(0.19--0.56)   0.54(0.30--0.97)   0.4115
  Swallow test done                                                0.59(0.35--0.99)   0.74(0.44--1.25)   0.83(0.47--1.47)   0.84(0.40--1.46)   0.3912
  Aspirin given in the acute phase                                 0.34(0.12--0.97)   0.47(0.21--0.94)   0.42(0.23--0.74)   0.41(0.19--0.85)   0.3699
  PTOT                                                             0.22(0.08--0.62)   0.25(0.13--0.48)   0.31(0.17--0.57)   0.39(0.20--0.74)   0.2432
  PTOT[\*](#nt101){ref-type="table-fn"}                            0.32(0.08--1.26)   0.22(0.11--0.46)   0.25(0.12--0.52)   0.15(0.06--0.39)   0.8349
  SALT                                                             0.30(0.11--0.84)   0.40(0.22--0.74)   0.32(0.18--0.56)   0.41(0.22--0.78)   0.2374
  SALT[\*](#nt101){ref-type="table-fn"}                            0.45(0.15--1.38)   0.44(0.21--0.92)   0.46(0.23--0.93)   0.36(0.16--0.83)   0.9979

excluding patients not admitted to a su.

P\<0.005 considered statistically significant.

10.1371/journal.pone.0061581.t003

###### Relative hazard of death following receipt of acute care interventions by gender.

![](pone.0061581.t003){#pone-0061581-t003-3}

                                                                   Gender, HR(95%CI)                     
  --------------------------------------------------------------- ------------------- ------------------ --------
  Hospital admission                                               2.11(1.20--3.72)    3.39(1.89--6.08)   0.7927
  Stroke unit admission                                            0.59(0.46--0.75)    0.67(0.54--0.82)   0.2305
  50% of stay on a stroke unit                                     0.68(0.52--0.90)    0.75(0.60--0.94)   0.2793
  50% of stay on a stroke unit[\*](#nt103){ref-type="table-fn"}    0.95(0.62--1.43)    1.14(0.79--1.66)   0.4317
  Brian imaging                                                    0.33(0.19--0.60)    0.48(0.31--0.74)   0.2146
  Swallow test done                                                0.72(0.49--1.06)    0.78(0.55--1.11)   0.3562
  Aspirin given inthe acute phase                                  0.36(0.21--0.61)    0.53(0.32--0.86)   0.5006
  PTOT                                                             0.24(0.14--0.39)    0.38(0.24--0.59)   0.4347
  PTOT[\*](#nt103){ref-type="table-fn"}                            0.29(0.14--0.57)    0.40(0.21--0.77)   0.3930
  SALT                                                             0.52(0.33--0.91)    0.30(0.20--0.45)   0.0987
  SALT[\*](#nt103){ref-type="table-fn"}                            0.85(0.48--1.50)    0.26(0.15--0.45)   0.0101

excluding patients not admitted to a su.

P\<0.005 considered statistically significant.

10.1371/journal.pone.0061581.t004

###### Relative hazard of death following receipt of acute care interventions by socioeconomic status and ethnicity.

![](pone.0061581.t004){#pone-0061581-t004-4}

                                                                   Socioeconomic status, HR(95%CI)   Ethnicity, HR(95%CI)                                                 
  --------------------------------------------------------------- --------------------------------- ---------------------- -------- ------------------ ------------------ --------
  Hospital admission                                                      2.71(1.17--6.25)             2.29(1.39--3.78)     0.5697   3.20(2.01--5.09)   1.54(0.55--4.31)   0.2593
  Stroke unit admission                                                   0.54(0.39--0.76)             0.74(0.59--0.94)     0.4719   0.64(0.54--0.76)   0.62(0.42--0.92)   0.4358
  50% of stay on a stroke unit                                            0.60(0.41--0.87)             0.69(0.53--0.89)     0.7237   0.70(0.57--0.84)   0.82(0.53--1.27)   0.5932
  50% of stay on a stroke unit[\*](#nt105){ref-type="table-fn"}           0.84(0.42--1.69)             0.81(0.57--1.16)     0.3446   0.96(0.71--1.29)   1.21(0.62--2.37)   0.4759
  Brian imaging                                                           0.33(0.10--1.08)             0.64(0.36--1.12)     0.4287   0.44(0.31--0.64)   0.47(0.15--1.45)   0.4022
  Swallow test done                                                       0.47(0.26--0.83)             0.69(0.47--1.02)     0.1549   0.64(0.48--0.84)   1.24(0.58--2.65)   0.2254
  Aspirin given inthe acute phase                                         0.37(0.15--0.90)             0.57(0.31--1.03)     0.4588   0.47(0.32--0.70)   0.24(0.09--0.62)   0.6308
  PTOT                                                                    0.56(0.47--1.17)             0.25(0.14--0.44)     0.0648   0.34(0.24--0.50)   0.31(0.14--0.69)   0.6803
  PTOT[\*](#nt105){ref-type="table-fn"}                                   0.18(0.04--0.79)             0.33(0.15--0.71)     0.4278   0.32(0.19--0.54)   0.35(0.11--1.10)   0.6803
  SALT                                                                    0.45(0.20--0.99)             0.63(0.38--1.06)     0.7169   0.39(0.27--0.56)   0.34(0.16--0.73)   0.6352
  SALT[\*](#nt105){ref-type="table-fn"}                                   0.59(0.18--1.90)             0.60(0.32--1.13)     0.3341   0.47(0.30--0.75)   0.49(0.19--1.13)   0.7488

excluding patients not admitted to a su.

P\<0.005 considered statistically significant.

10.1371/journal.pone.0061581.t005

###### Relative hazard of death following the receipt of acute care interventions by stroke subtype and GCS.
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                                                                   Subtype, HR (95% CI)   GCS, HR (95% CI)                                                                      
  --------------------------------------------------------------- ---------------------- ------------------ ---------- ------------------ ------------------ ------------------ ---------
  Stroke unit admission                                              0.74(0.62--0.89)     0.39(0.27--0.57)    0.0052    0.44(0.33--0.58)   0.48(0.33--0.70)   0.98(0.78--1.23)   0.0238
  50% of stay on a stroke unit                                       0.79(0.66--0.96)     0.56(0.37--0.86)    0.0875    0.60(0.45--0.81)   0.73(0.49--1.07)   0.93(0.72--1.22)   0.8396
  50% of stay on a stroke unit[\*](#nt107){ref-type="table-fn"}      1.05(0.78--1.41)     1.35(0.68--2.68)    0.8410    1.27(0.75--2.17)   1.52(0.85--2.69)   0.77(0.51--1.15)   0.3486
  Brian imaging                                                      0.43(0.30--0.62)     0.47(0.14--1.58)    0.2520    0.37(0.23--0.62)   0.49(0.19--1.30)   0.90(0.48--1.66)   0.2929
  Swallow test done                                                  0.78(0.57--1.07)     0.68(0.41--1.12)    0.1014    0.66(0.45--0.96)   0.38(0.21--0.71)   1.17(0.73--1.87)   0.0134
  Aspirin given inthe acute phase                                           NA                   NA             NA      0.33(0.18--0.61)   0.29(0.12--0.67)   0.77(0.43--1.36)   0.0007
  PTOT                                                               0.47(0.32--0.68)     0.07(0.03--0.22)   \<0.0001   0.13(0.07--0.24)   0.20(0.09--0.46)   0.83(0.40--1.71)   \<0.001
  PTOT[\*](#nt107){ref-type="table-fn"}                              0.46(0.27--0.80)     0.04(0.01--0.22)    0.0041    0.10(0.04--0.23)   0.16(0.04--0.73)   0.85(0.36--2.01)   0.0005
  SALT                                                               0.45(0.32--0.64)     0.21(0.09--0.45)    0.0141    0.15(0.09--0.26)   0.12(0.05--0.29)   1.38(0.76--2.48)   \<0.001
  SALT[\*](#nt107){ref-type="table-fn"}                              0.52(0.34--0.81)     0.26(0.09--0.76)    0.2736    0.11(0.05--0.25)   0.21(0.05--0.95)   1.32(0.70--2.48)   \<0.001

excluding patients not admitted to a su.

P\<0.005 considered statistically significant.

NA not applicable.

After allowing for multiple testing, there were no statistically significant interactions between the receipt of careand gender ([Table 3](#pone-0061581-t003){ref-type="table"}), ethnicity or socioeconomic status ([Table 4](#pone-0061581-t004){ref-type="table"}).

[Table 5](#pone-0061581-t005){ref-type="table"} shows the interactions between acute care interventions and clinical sub groups of patients. Although not statistically significant and the p\<0.005 level,s, there was a borderline interaction (p = 0.0052) between stroke unit care and subtype with stroke unit admission associated with a 61% reduction in the hazard of death in patients with a haemorrhagic stroke (HR: 0.39; CI: 0.27--0.57) compared to 26% reduction in those with ischaemic stroke (HR: 0.74; 95% CI: 0.62--0.89). There were significant interactions between stroke subtype and the receipt of PT/OT. and between the level of consciousness (GCS level) and the receipt of aspirin and rehabilitation therapy in the acute phase. The largest reductions in the hazards of death in these instances were observed in unconscious patients (GCS \<9) compared to those with higher levels of consciousness (GCS 13--15).

Discussion {#s4}
==========

This population-based study showed a better one year survival in patients who received acute care interventions including stroke unit care, rehabilitation therapies and aspirin after an acute stroke compared to those who did not. The largest reduction in the hazards of death among patients managed on a stroke unit were observed in younger patients (\<65 years) compared to older patients, those with a haemorrhagic stroke compared to an infarct, and patients who were unconscious at the time of admission (GCS \<9) compared to conscious patients (GCS ≥9). Receipt of aspirin among patients with ischaemic stroke and rehabilitation therapy where there were deficits, were associated with better one year survival in unconscious patients (GCS \<9) compared to more conscious patients (GCS ≥9). These findings were independent of stroke unit care.

The findings of better survival after receipt of acute care interventions in this study are similar to previously reported results from randomised trials.[@pone.0061581-Indredavik3]--[@pone.0061581-Ronning1] Few studies have examined the effect of acute care interventions on subgroups of stroke patients in observational studies.[@pone.0061581-Stegmayr1]--[@pone.0061581-Candelise1] With the exception of patients with intracranial haemorrhage who had better outcome when managed on a stroke unit in an observational study which included stroke patients admitted to several hospitals in Italy, there were no significant interactions between stroke unit care and other patient characteristics. [@pone.0061581-Candelise1] Similar to the findings of our study however, results from the Riks-Stroke study involving all hospitals admitting stroke patients in Sweden, demonstrated better survival associated with stroke unit care in all patients, with greater effect in younger patients, those with intracerebral haemorrhage and patients who were unconscious. [@pone.0061581-Terent2] Significant differences in management and complications between stroke units and general wards have been reported as possible explanations for the more favourable outcome seen in patients on stroke units compared to general wards. [@pone.0061581-Indredavik4], [@pone.0061581-Evans1] Patients with more severe strokes may require more specialised care compared to milder strokes and such care is probably best provided in a stroke unit than on a general ward. This may be a possible explanation for the survival advantage observed in such patients with stroke unit care. These findings may be relevant in situations where difficulties in accessing acute care interventions such as unavailability of stroke unit beds may warrant prioritisation of stroke patients according to those likely to have the greatest benefits. It is however possible that these findings could have been different for patients with milder strokes if the outcome measure was dependency and not death as used in this study. Interestingly, just receiving care on a stroke unit and not necessarily the proportion of hospital admission time spent receiving such an intervention, had beneficial effects on one year survival. Although, these findings were adjusted for case mix differences this may be due to unmeasured confounders. If patients with the poorest prognosis are those spending the longest time on a stroke unit, this could potentially confound results and mask any survival advantages associated with spending a greater proportion of hospital stay on a stroke unit This study also showed the beneficial effects of acute care interventions beyond stroke unit care, such as rehabilitation therapies and aspirin therapy in patients with reduced levels of consciousness, emphasising the need to ensure accessibility of appropriate interventions to patients regardless of stroke severity and subtype.

A previous study from this multiethnic South London population reported inequalities in access to acute care interventions with patients of black ethnicity more likely to be admitted to a stroke unit, and older patients as well as those of lower socioeconomic status less likely to have brain imaging. [@pone.0061581-Addo1] The results of the present study provide no evidence to justify the existence of such inequalities to acute care interventions, as there was no survival advantage observed in these subgroups of patients above others.

This study controlled for case mix differences in the analyses, but there could still be potential for residual confounding. The inequalities described above, in access to some of the interventions may potentially lead to bias when determining the size of the association between intervention and survival. However, unless different, unmeasured, selection criteria were being applied to patients in each subgroup assessed in this study, it is unlikely unmeasured confounders would bias the interaction between intervention and subgroup.

The various components of stroke unit care considered were by no means exhaustive, and additionally, although the organised care components included rehabilitation therapies, it did not consider the number of therapy sessions and the duration between onset of symptoms and receipt of these therapies which could potentially affect outcome. In the future assessing whether intensity of therapies and contact with the wider multidisciplinary team has increased beneficial impact on outcome within certain subgroups of patients would be of interest. It is also possible that some patients with severe clinical impairments and co- morbidities or those who developed complications after stroke were admitted, or transferred, to other wards apart from stroke units, which could potentially have influenced the outcome examined in the study.

Despite these limitations, the present study using detailed information from a population-based stroke register with high case-ascertainment rates (shown to be around 80%) and with unselected patients has enabled us to examine the effects of implementing evidence-based acute stroke care interventions on one year survival. [@pone.0061581-Heuschmann1] The present study using detailed information from a population-based stroke register with high case-ascertainment rates (shown to be around 80%) and with unselected patients has enabled us to examine the effects of implementing evidence-based acute stroke care interventions on one year survival. [@pone.0061581-Heuschmann1] A strength of this study is the ability to study the effect of the acute care interventions on subgroups of stroke patients. As a result of the cohort design of the study, information on the patients' characteristics and interventions received were collected before the onset of the outcome (death) by independent observers who were unaware of any study hypothesis, thus limiting the possibility of bias occurring. Information on death was also complete and was confirmed by the UK Office of National Statistics.

In conclusion, the findings of this study suggest an improvement in one year survival in patients receiving specific acute care interventions after stroke with a significantly greater effect observed in younger patients, those with haemorrhagic strokes and those with reduced level of consciousness in the acute phase in this multiethnic population. These findings provide a platform upon which to re-organise the delivery of acute stroke care to encourage universal access to these services, with the possibility of ensuring that subgroups of patients shown to derive the most benefits from acute care interventions receive the most appropriate care as a matter of priority.
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